NYBC Enterprises Community Report - Page 15

NYBC CELL THERAPY LAB HAS PROCESSED

18,000 +

HEMATOPOIETIC STEM CELL PRODUCTS
EDUCATION PROGRAMS PROVIDED TO

10,000 +

RESEARCHERS , PHYSICIANS AND STUDENTS

18 RESEARCH FACULTY STUDYING TRANSFUSION EPIDEMIOLOGY , BLOOD COMPONENT THERAPEUTICS , TRANSFUSION-TRANSMITTED INFECTIOUS DISEASE , AND TRANSFUSION IMMUNOLOGY

14 / NYBCe COMMUNITY REPORT